Choose Language
Select a language for news translation.
Written by Reuben Gregg Brewer for The Motley Fool -> Eli Lilly is probably best known for its dominant GLP-1 drugs right now. The company's recent $3.8 bill…
EXCLUSIVE: Executive producers Margaret Cho and Lilly Wachowski have wrapped production on transgender comedian Nina Nguyen’s debut stand-up special. Directed …
Written by Jeff Siegel for The Motley Fool -> Eli Lilly now controls roughly 60% of the GLP-1 market. International growth could become Lilly's next major ca…
Written by Reuben Gregg Brewer for The Motley Fool -> Wall Street likes stories, and a big one today is the huge demand for GLP-1 weight-loss drugs. Novo Nor…
Written by Prosper Junior Bakiny for The Motley Fool -> Eli Lilly has worked hard to diversify its pipeline. Three new acquisitions will further help decreas…
One of the biggest misconceptions about ETFs is that they are highly diversified “baskets” of stocks. Sometimes they are. But as the iShares US Pharmaceuticals…



























